Project BioShield Act of 2004
Official title: A bill to amend the Public Health Service Act to provide protections and countermeasures against chemical, radiological, or nuclear agents that may be used in … Show full official titleShow less
Official title: A bill to amend the Public Health Service Act to provide protections and countermeasures against chemical, radiological, or nuclear agents that may be used in a terrorist attack against the United States by giving the National Institutes of Health contracting flexibility, infrastructure improvements, and expediting the scientific peer review process, and streamlining the Food and Drug Administration approval process of countermeasures.
More subjectsShow fewer subjects
| Date | Chamber | What was voted on | Result | Yes–No | |
|---|---|---|---|---|---|
| Jul 14, 2004 | House · vote #376 | On Passage | Passed | 414–2 | See who voted → |
| May 19, 2004 | Senate · vote #99 | On Passage of the Bill S. 15 | Passed | 99–0 | See who voted → |
Amendments propose changes to this bill. Members vote on amendments separately before the final bill vote. An agreed amendment becomes part of the bill; a failed amendment does not.
2 agreed to
| Amendment | Sponsor | Status |
|---|---|---|
| SAMDT 3,180 | – | Agreed to |
| SAMDT 3,178 | – | Agreed to |
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Became Public Law No: 108-276.
Project Bioshield Act of 2003 - Permits the Secretary to conduct and support research and development with respect to biomedical countermeasures.
Directs the Secretary, on an ongoing basis, to assess threats of use of chemical, biological, radiological, and nuclear agents and procure biomedical countermeasures to such threats.
Allows the Secretary to declare a national emergency under specified conditions and authorize the release of a drug or device intended solely for use in an emergency.
Improved Vaccine Affordability and Availability Act - Amends the Public Health Service Act to direct the Secretary to: (1) develop and disseminate information concerning certain diseases and their vaccines, including bacterial meningitis and hepatitis A and B; and (2) maintain a six months supply of prioritized vaccines.
Revises provisions governing the National Vaccine Injury Compensation Program, including provisions regarding: (1) equitable relief; (2) derivative petitions; and (3) an extension of the statute of limitations.
Amends Internal Revenue Code provisions concerning the Vaccine Injury Compensation Trust Fund, including to expand compensated loss for injury or death to include related loss.
Amends the Public Health Service Act to require the Secretary to contract with the Institute of Medicine of the National Academy of Science to conduct an ongoing, comprehensive review of new scientific data on childhood vaccines.
- Engrossed in Senate Formatted Text PDF
- Enrolled Bill Formatted Text PDF
- Introduced in Senate Formatted Text PDF
- Public Law Formatted Text PDF
- Reported to Senate Formatted Text PDF
Cite this page
U.S. Congress. (2026). S. 15: Project BioShield Act of 2004. 108th Congress. Open America. https://openamerica.io/bill/108-S-15/
"S. 15: Project BioShield Act of 2004." 108th Congress, 2026, Open America, https://openamerica.io/bill/108-S-15/.
S. 15, 108th Cong. (2026), https://openamerica.io/bill/108-S-15/.
[S. 15: Project BioShield Act of 2004](https://openamerica.io/bill/108-S-15/)